Sutro Biopharma (STRO) Invested Capital (2017 - 2023)
Sutro Biopharma (STRO) posted Invested Capital of $4.1 million for Q4 2023, down 43.1% sequentially from $7.1 million in Q3 2023, and down 67.51% YoY from $12.5 million in Q4 2022.
Sutro Biopharma (STRO) Invested Capital (2017 - 2023) Analysis & Trends
Sutro Biopharma has reported Invested Capital for 6 years, with the latest figure at $4.1 million in Q4 2023.
- Quarterly Invested Capital fell 67.51% year-over-year to $4.1 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $4.1 million (down 90.57% YoY) and the FY2023 annual result came in at $4.1 million, down 67.51% from the prior year.
- Invested Capital retreated to $4.1 million in Q4 2023 per STRO's latest filing, from $7.1 million in the prior quarter.
- Over five years, Invested Capital peaked at $13.2 million in Q1 2023 and troughed at $1.0 million in Q4 2019.
- A 4-year average of $8.1 million and a median of $7.1 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2019 and 2022: Invested Capital plunged 78.83% in 2019, then soared 300.0% in 2022.
- Over 4 years, Invested Capital stood at $1.0 million in 2019, then soared by 837.5% to $9.4 million in 2021, then jumped by 33.33% to $12.5 million in 2022, then plunged by 67.51% to $4.1 million in 2023.
- According to Business Quant data, Invested Capital over the past three periods registered $4.1 million, $7.1 million, and $10.2 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 7.14 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Mar 31, 2023 | 13.24 Mn |
| Dec 31, 2022 | 12.50 Mn |
| Sep 30, 2022 | 12.50 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 12.50 Mn |
| Dec 31, 2021 | 9.38 Mn |
| Sep 30, 2021 | 6.25 Mn |
| Jun 30, 2021 | 3.13 Mn |
| Dec 31, 2019 | 1.00 Mn |
| Sep 30, 2019 | 5.84 Mn |
| Jun 30, 2019 | 5.81 Mn |
| Mar 31, 2019 | 5.77 Mn |
| Dec 31, 2018 | 4.72 Mn |
| Sep 30, 2018 | 3.18 Mn |
| Dec 31, 2017 | 14.56 Mn |